H.R. 4764: Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020
CBO Score
$220 million
Documentation
Date of Report
Wed December 23rd, 2020
CBO Report Details
Legislation Details
116th Congress
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
Sponsor: Rep. Doris Matsui — D — CA
Modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies. Specifically, the Department of Health and Human Services...
JOIN US!
Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.
Lost your Password?
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.
×